143 related articles for article (PubMed ID: 32452658)
41. Radiotherapy in marginal zone lymphoma.
Deinbeck K; Geinitz H; Haller B; Fakhrian K
Radiat Oncol; 2013 Jan; 8():2. PubMed ID: 23281682
[TBL] [Abstract][Full Text] [Related]
42. Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.
Meyer AH; Stroux A; Lerch K; Eucker J; Eitle J; Hohloch K; Andrzejak M; Possinger K; Dörken B; Pezzutto A; Scholz CW
Ann Oncol; 2014 Jan; 25(1):210-5. PubMed ID: 24356632
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma.
Wang L; Ye G; Liu Z; Shi L; Zhan C; Gu J; Luo R; Lin Z; Ge D; Wang Q
Cancer Med; 2019 Dec; 8(18):7660-7668. PubMed ID: 31691549
[TBL] [Abstract][Full Text] [Related]
44. Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).
Reinartz G; Pyra RP; Lenz G; Liersch R; Stüben G; Micke O; Willborn K; Hess CF; Probst A; Fietkau R; Jany R; Schultze J; Rübe C; Hirt C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Möller P; Neubauer A; Wilhelm M; Willich N; Berdel WE; Eich HT
Strahlenther Onkol; 2019 Jun; 195(6):544-557. PubMed ID: 30859254
[TBL] [Abstract][Full Text] [Related]
45. Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.
Noy A; de Vos S; Thieblemont C; Martin P; Flowers CR; Morschhauser F; Collins GP; Ma S; Coleman M; Peles S; Smith S; Barrientos JC; Smith A; Munneke B; Dimery I; Beaupre DM; Chen R
Blood; 2017 Apr; 129(16):2224-2232. PubMed ID: 28167659
[TBL] [Abstract][Full Text] [Related]
46. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma.
Saul EE; Alderuccio JP; Reis IM; Zhao W; Iyer SG; Rodriguez G; Desai A; Chapman JR; Tse DT; Markoe AM; Isrow DM; Lossos IS
Am J Hematol; 2023 Jan; 98(1):148-158. PubMed ID: 35560252
[TBL] [Abstract][Full Text] [Related]
48. Clinical characteristics and prognostic factors of pulmonary MALT lymphoma.
Borie R; Wislez M; Thabut G; Antoine M; Rabbat A; Couderc LJ; Monnet I; Nunes H; Blanc FX; Mal H; Bergeron A; Dusser D; Israël-Biet D; Crestani B; Cadranel J
Eur Respir J; 2009 Dec; 34(6):1408-16. PubMed ID: 19541720
[TBL] [Abstract][Full Text] [Related]
49. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
50. Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Papaxoinis G; Fountzilas G; Rontogianni D; Dimopoulos MA; Pavlidis N; Tsatalas C; Pectasides D; Xiros N; Economopoulos T
Ann Oncol; 2008 Apr; 19(4):780-6. PubMed ID: 18156143
[TBL] [Abstract][Full Text] [Related]
51. Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.
Tsai HK; Li S; Ng AK; Silver B; Stevenson MA; Mauch PM
Ann Oncol; 2007 Apr; 18(4):672-8. PubMed ID: 17218489
[TBL] [Abstract][Full Text] [Related]
52. Lenalidomide plus rituximab (R
Becnel MR; Nastoupil LJ; Samaniego F; Davis RE; You MJ; Green M; Hagemeister FB; Fanale MA; Fayad LE; Westin JR; Wang M; Oki Y; Forbes SG; Feng L; Neelapu SS; Fowler NH
Br J Haematol; 2019 Jun; 185(5):874-882. PubMed ID: 30919940
[TBL] [Abstract][Full Text] [Related]
53. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
[TBL] [Abstract][Full Text] [Related]
54. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Bult JAA; Huisman F; Zhong Y; Veltmaat N; Kluiver J; Tonino SH; Vermaat JSP; Chamuleau MED; Diepstra A; van den Berg A; Plattel WJ; Brink M; Nijland M
Blood Cancer J; 2023 Sep; 13(1):130. PubMed ID: 37658062
[TBL] [Abstract][Full Text] [Related]
55. A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG).
Sammassimo S; Pruneri G; Andreola G; Montoro J; Steffanoni S; Nowakowski GS; Gandini S; Negri M; Habermann TM; Raderer M; Li ZM; Zinzani PL; Adam P; Zucca E; Martinelli G
Hematol Oncol; 2016 Dec; 34(4):177-183. PubMed ID: 26152851
[TBL] [Abstract][Full Text] [Related]
56. Long-Term Outcomes of 107 Cases of Primary Thyroid Mucosa-Associated Lymphoid Tissue Lymphoma at a Single Medical Institution in Japan.
Watanabe N; Narimatsu H; Noh JY; Iwaku K; Kunii Y; Suzuki N; Ohye H; Suzuki M; Matsumoto M; Yoshihara A; Kameyama K; Kobayashi K; Kami M; Sugino K; Ito K
J Clin Endocrinol Metab; 2018 Feb; 103(2):732-739. PubMed ID: 29165612
[TBL] [Abstract][Full Text] [Related]
57. Complete metabolic response (CMR) in positron emission tomography-computed tomography (PET-CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL).
Park JH; Kim S; Ryu JS; Lee SW; Park CS; Huh J; Suh C
Hematol Oncol; 2018 Feb; 36(1):56-61. PubMed ID: 28401574
[TBL] [Abstract][Full Text] [Related]
58. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
59. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
60. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
